Literature DB >> 12741685

The skeleton as a unique environment for breast cancer cells.

Andrea M Mastro1, Carol V Gay, Danny R Welch.   

Abstract

Bone is a favored location for several cancer metastases especially breast, prostate and myeloma. This review evaluates various properties of the skeleton that contribute to its successful colonization by breast cancer cells. The first consideration is the unique aspects of the vasculature of metaphyseal bone, which may account for the initial lodging of breast cancer cells in specific regions of the skeleton. Metasphyseal bone, found at the ends of long bone, in ribs and in vertebrae, is comprised of trabecular bone interspersed with marrow and a rich vasculature. The chemotactic factors that arise from bone marrow and bone cells are discussed in terms of cancer cell migration out of the vasculature and entry of cancer cells into the marrow cavity. Once the breast cancer cells have migrated into the metaphysis, they interact both directly and indirectly with bone cells and other cells in the marrow. As tumor growth progresses, functional bone cells are lost, most likely through apoptosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12741685     DOI: 10.1023/a:1022995403081

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  31 in total

Review 1.  Molecular alterations that drive breast cancer metastasis to bone.

Authors:  Penelope D Ottewell; Liam O'Donnell; Ingunn Holen
Journal:  Bonekey Rep       Date:  2015-03-18

Review 2.  The Yin and Yang of bone morphogenetic proteins in cancer.

Authors:  Ashok Singh; Rebecca J Morris
Journal:  Cytokine Growth Factor Rev       Date:  2010-08-04       Impact factor: 7.638

3.  In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment.

Authors:  Dorothy A Sipkins; Xunbin Wei; Juwell W Wu; Judith M Runnels; Daniel Côté; Terry K Means; Andrew D Luster; David T Scadden; Charles P Lin
Journal:  Nature       Date:  2005-06-16       Impact factor: 49.962

4.  Bosentan inhibits tumor vascularization and bone metastasis in an immunocompetent skin-fold chamber model of breast carcinoma cell metastasis.

Authors:  Didier Dréau; Amel Karaa; Cathy Culberson; Heather Wyan; Iain H McKillop; Mark G Clemens
Journal:  Clin Exp Metastasis       Date:  2006-07-07       Impact factor: 5.150

5.  Practical update for the use of bone-targeted agents in patients with bone metastases from metastatic breast cancer or castration-resistant prostate cancer.

Authors:  D Southcott; A Awan; K Ghate; M Clemons; R Fernandes
Journal:  Curr Oncol       Date:  2020-08-01       Impact factor: 3.677

6.  Multiscale characterization of the mineral phase at skeletal sites of breast cancer metastasis.

Authors:  Frank He; Aaron E Chiou; Hyun Chae Loh; Maureen Lynch; Bo Ri Seo; Young Hye Song; Min Joon Lee; Rebecca Hoerth; Emely L Bortel; Bettina M Willie; Georg N Duda; Lara A Estroff; Admir Masic; Wolfgang Wagermaier; Peter Fratzl; Claudia Fischbach
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-18       Impact factor: 11.205

7.  Walker 256/B malignant breast cancer cells improve femur angioarchitecture and disrupt hematological parameters in a rat model of tumor osteolysis.

Authors:  Riadh Badraoui; Mariem Boubakri; Maissa Bedbabiss; Hmed Ben-Nasr; Tarek Rebai
Journal:  Tumour Biol       Date:  2013-12-08

8.  Three-dimensional characterization of the vascular bed in bone metastasis of the rat by microcomputed tomography (MicroCT).

Authors:  Hervé Nyangoga; Philippe Mercier; Hélène Libouban; Michel Félix Baslé; Daniel Chappard
Journal:  PLoS One       Date:  2011-03-28       Impact factor: 3.240

9.  BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process.

Authors:  Pushkar A Phadke; Kedar S Vaidya; Kevin T Nash; Douglas R Hurst; Danny R Welch
Journal:  Am J Pathol       Date:  2008-02-14       Impact factor: 4.307

10.  Human breast cancer bone metastasis in vitro and in vivo: a novel 3D model system for studies of tumour cell-bone cell interactions.

Authors:  I Holen; F Nutter; J M Wilkinson; C A Evans; P Avgoustou; Penelope D Ottewell
Journal:  Clin Exp Metastasis       Date:  2015-08-01       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.